Pharmacorp Rx Inc. (TSE:PCRX) has released an update.
Pharmacorp Rx Inc. has announced the acquisition of a fully-owned pharmacy in Atlantic Canada, with the deal comprising a mix of cash and stock valued at $15.38 million. The purchase, which includes land and buildings, is set to close on October 1, 2024, and follows PharmaCorp’s recent strategic acquisitions in partnership with PharmaChoice Canada.
For further insights into TSE:PCRX stock, check out TipRanks’ Stock Analysis page.